Tuesday - December 09, 2025

Category Archives: Science

Diarrhea Pipeline Drugs Insights Report 2025: Promising Drugs and MOA Innovations Reshape Future Treatment Approaches | DelveInsight

DelveInsight’s “Diarrhea Pipeline Insight 2025” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in the Diarrhea pipeline landscape. It covers the Diarrhea Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diarrhea Pipeline … Continue reading →

Musculoskeletal Pain Treatment Market Size (7MM) is expected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Musculoskeletal Pain Market Insight, Epidemiology and Market Forecast – 2034” report delivers an in-depth analysis of musculoskeletal pain epidemiology, market, and clinical development in musculoskeletal pain. In addition to this, the report provides historical and forecasted epidemiology and market … Continue reading →

ATNM-400 Targets B7-H3 and Is Being Studied in a Phase 1 Clinical Trial in South Africa

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) is expanding its radiotherapeutic platform beyond hematologic cancers with ATNM-400, a next-generation candidate designed to deliver targeted radiation against B7-H3, an immune-checkpoint molecule highly expressed across multiple solid tumors. B7-H3 overexpression is linked to … Continue reading →

Cutaneous Squamous Cell Carcinoma Pipeline Drugs Insights Report 2025: Promising Drugs and MOA Innovations Reshape Future Treatment Approaches | DelveInsight

DelveInsight’s, “Cutaneous Squamous Cell Carcinoma Pipeline Insight 2025” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Cutaneous Squamous Cell Carcinoma pipeline landscape. It covers the Cutaneous Squamous Cell Carcinoma pipeline drug profiles, including clinical and nonclinical … Continue reading →

Osteoarthritis Pipeline Drugs Insights Report 2025: Promising Drugs and MOA Innovations Reshape Future Treatment Approaches | DelveInsight

DelveInsight’s, “Osteoarthritis Pipeline Insights 2025” report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in Osteoarthritis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product … Continue reading →

Diabetes Pipeline Drugs Insights Report 2025: Promising Drugs and MOA Innovations Reshape Future Treatment Approaches | DelveInsight

DelveInsight’s “Diabetes Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in the Diabetes pipeline landscape. It covers the Diabetes pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetes therapeutics … Continue reading →

Motiqa Cloud Launches Revolutionary $6.29/Month Platform for Unlimited AI-Generated Faceless Video Content Creation

“We’ve democratized content creation by making it possible for anyone to produce viral-worthy videos without the barriers of camera shyness, expensive equipment, or time-consuming editing. At $6.29 per month for unlimited content, we’re removing the financial obstacles that prevent creators … Continue reading →